Services-Offices & Clinics of Doctors of Medicine · SIC 8011

HealthLynked Corp

HLYK

Watch

Latest revenue

$423.5K

as of 2026-03-31

Latest net income

$-1.6M

as of 2026-03-31

Net margin

-382.9%

as of 2026-03-31

Price · 5Y

-50.7% / yr 64.5 pts / yr vs S&P 500 97.1% total
Compare:

Live market

delayed ≤15 min
$2.05
6.82%
Market cap
$6.0M
Enterprise value
$6.0M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$6.50
52-wk low
$0.02
Beta
Shares out
2.9M

5-year trend

What this company does

AI

Item 1. Business Overview HealthLynked Corp. (the “Company,” “we,” “our,”) is a healthcare technology company incorporated in the State of Nevada on August 6, 2014. We operate across three primary divisions – Digital Healthcare, Health Services, and Medical Distribution – each dedicated to leveraging innovative solutions that enhance patient care, reduce costs, and generate long-term value for stockholders. Our key objectives are to: 1. Improve patient care management; 2. Enhance the operational efficiency of medical practices; and 3. Utilize healthcare data to gain unique insights into diseases, leading to better health outcomes Digital Healthcare Division Within our Digital Healthcare…

AI summary unavailable — showing raw filing excerpt

Generated from HLYK's filing dated 2026-03-31

Key risks

AI

Item 1A. Risk Factors Our business, financial condition, results of operations and cash flows may be affected by a number of factors including, but not limited to those set forth below. This discussion should be considered in conjunction with the discussion under the caption “Forward-Looking Statements” preceding Part I, the information set forth under Item 1, “Business” and with the discussion of the business included in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These risks comprise the material risks of which we are aware. If any of the events or developments described below or elsewhere in this Annual Report on Form 10-K, or…

AI summary unavailable — showing raw filing excerpt

Generated from HLYK's filing dated 2026-03-31

Profitability

Operating margin

-155.5%

114.3%

Net margin

-158.8%

22.1%

Return on equity

56.9%

70.9%

Return on assets

-192.7%

30.1%

Leverage

Debt / equity

-1.30×

24.3%

Long-term debt / equity

0.46×

21.4%

Debt / assets

438.5%

82.1%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$423.5K-45.3%$-1.6M-54.3%-382.9%

Q4 2025

2025-12-31

$310.2K-49.9%$-676.5K+45.0%-218.1%

Q3 2025

2025-09-30

$388.5K-34.2%$-851.8K+56.8%-219.2%

Q2 2025

2025-06-30

$592.4K-25.5%$-701.0K+54.5%-118.3%

Q1 2025

2025-03-31

$774.2K-22.9%$-1.1M+24.3%-135.7%

Q4 2024

2024-12-31

$618.9K$-1.2M-198.8%

Q3 2024

2024-09-30

$590.1K-55.7%$-2.0M-1028.0%-334.4%

Q2 2024

2024-06-30

$795.1K-51.2%$-1.5M-443.5%-193.7%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Services-Offices & Clinics of Doctors of Medicine · SIC 8011

No data yet for industry average

Your notes

Keep private notes on HLYK — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

No insider transactions on file for HLYK in the last 12 months.

Source: SEC Form 4 filings. Backfill runs nightly.

Who owns HLYK

No institutional holdings on file for HLYK yet.

Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).

Top questions investors are asking

Coming once HLYK's latest filing finishes processing.